FDA Approved: ARIMIDEX — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved ANI Pharmaceuticals' supplemental application for ARIMIDEX (anastrozole) under NDA 020541.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)

Snippet

SUPPL AP for ARIMIDEX (ANASTROZOLE)